Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES).
Cheng Y, Wu L, Huang D, Wang Q, Fan Y, Zhang X, Fan H, Yao W, Liu B, Yu G, Pan Y, Xu F, He Z, Dong X, Ma R, Min X, Ge X, Chen H, Liu Q, Hu Y, Liu Y, Yang C, Yang Y, Li X, Zhou L.
Cheng Y, et al. Among authors: fan h, fan y.
Lung Cancer. 2024 Feb;188:107455. doi: 10.1016/j.lungcan.2023.107455. Epub 2023 Dec 31.
Lung Cancer. 2024.
PMID: 38224653
Free article.
Clinical Trial.